RecruitingPhase 4NCT02803294

Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

2,000 participants

Start Date

Jun 1, 2016

Study Type

INTERVENTIONAL

Conditions

The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.

Min Age: 18 Years

Patients with symptomatic aortic stenosis/regurgitation
Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
The subject agrees to comply with specified follow-up evaluations and to return to the investigational site where the procedure was performed.
Patients are technical and anatomical eligible for interventions

A known hypersensitivity or contraindication to any of the following which cannot be adequately pre-medicated: Aspirin Heparin (HIT/HITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media
Subject refuses a blood transfusion.
Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent.
Life expectancy is less than one year

Interested in this trial?

Get notified about updates and connect with the research team.

PROCEDUREtranscatheter aortic valve replacement

The Second Affiliated Hospital, School of Medicine at Zhejiang University

Hanzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT02803294